Capital International Ltd. CA Reduces Position in Corteva, Inc. $CTVA

Capital International Ltd. CA lowered its holdings in Corteva, Inc. (NYSE:CTVA) by 9.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 223,024 shares of the company’s stock after selling 23,949 shares during the period. Capital International Ltd. CA’s holdings in Corteva were worth $15,083,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Brighton Jones LLC increased its stake in shares of Corteva by 307.2% in the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after buying an additional 11,760 shares during the last quarter. Woodline Partners LP increased its position in shares of Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after purchasing an additional 16,644 shares during the last quarter. Savant Capital LLC lifted its position in shares of Corteva by 20.7% during the second quarter. Savant Capital LLC now owns 20,711 shares of the company’s stock worth $1,544,000 after purchasing an additional 3,548 shares during the last quarter. Wedbush Securities Inc. grew its stake in Corteva by 11.7% in the second quarter. Wedbush Securities Inc. now owns 5,253 shares of the company’s stock worth $391,000 after purchasing an additional 549 shares in the last quarter. Finally, Fox Run Management L.L.C. bought a new stake in Corteva in the second quarter valued at about $238,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Rothschild & Co Redburn lowered their price target on Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a report on Tuesday, November 11th. BNP Paribas Exane increased their price objective on shares of Corteva from $72.00 to $74.00 in a report on Monday. Oppenheimer set a $86.00 target price on shares of Corteva in a research note on Thursday, February 5th. Wells Fargo & Company raised their price target on shares of Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Corteva has an average rating of “Moderate Buy” and an average price target of $82.90.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.15% of the stock is currently owned by insiders.

Corteva Price Performance

Shares of NYSE CTVA opened at $78.36 on Tuesday. Corteva, Inc. has a twelve month low of $53.40 and a twelve month high of $80.90. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The firm has a 50-day moving average of $73.22 and a two-hundred day moving average of $69.04. The company has a market capitalization of $52.70 billion, a price-to-earnings ratio of 49.59, a PEG ratio of 2.63 and a beta of 0.72.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. The business had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s payout ratio is presently 45.57%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.